Repligen (NASDAQ:RGEN) Releases FY23 Earnings Guidance
Repligen (NASDAQ:RGEN – Get Rating) updated its FY23 earnings guidance on Tuesday. The company provided earnings per share guidance of $2.35-$2.42 for the period, compared to the consensus earnings per share estimate of $2.64. The company issued revenue guidance of $720-$760 million, compared to the consensus revenue estimate of $779.97 million. Wall Street Analyst Weigh […]